Coronavirus treatment with remdesivir to cost $2,340 per patient
Kyodo -- Jun 30
Gilead Sciences Inc. said Monday that its experimental anti-coronavirus drug remdesivir will be supplied to the governments of developed countries at what it sees as an affordable price of $2,340 per patient for a typical five-day treatment course.

The U.S. biopharmaceutical company has been donating worldwide, including to Japan, doses of the anti-viral drug that has demonstrated patient improvement in clinical trials for the disease triggered by the novel coronavirus. But it had not been clear what the price tag of the drug would be after the donations ended.

The U.S. Department of Health and Human Services said it has secured more than 500,000 treatment courses of the drug for the country's hospitals through September, which represents most of Gilead's projected production for the three months from July.

A treatment course of remdesivir is, on average, about six vials, according to the department.

Gilead said in a press release that it will charge governments $390 per vial.

News source: Kyodo
Jul 12
Scientists have been studying the coronavirus around the clock since it first emerged, but much about the virus still remains a mystery. Recently, reports have emerged of former patients suffering symptoms such as fever and shortness of breath long after testing negative. Doctors and researchers are now studying these lingering effects. (NHK)
Jul 11
Japan's science ministry and the US space agency NASA have agreed to discuss cooperation plans that could lead to Japanese astronauts visiting the moon. (NHK)
Jul 11
Japan's government is pushing to solve a dispute over a super-fast transport link in the country. The conflict is threatening to delay the 84-billion-dollar magnetically levitated, or maglev, train project. (NHK)
Jul 11
A group of researchers in Japan say their clinical study of the anti-flu drug Avigan, a candidate for treating COVID-19, could not confirm statistical significance regarding its effectiveness. (NHK)
Jul 10
Japan will tighten its criteria for supporting exports of coal-fired power plants amid criticism that the practice goes against global efforts to curb global warming. (Japan Times)
Jul 05
Japanese researchers say recent volcanic activity on Nishinoshima has caused the remote island in the Pacific to increase in size. (NHK)
Jul 05
Alpine plants have come under threat of extinction from the sudden expansion of a species of dwarf bamboo in mountainous regions of Japan. (Kyodo)
Jul 03
The Japanese government will urge the closure or suspension of about 100 low-efficiency coal-fired power plants in the country by fiscal year 2030 in the face of international pressure for a transition to greener alternatives. (Nikkei)
Jul 03
Night sky watchers say what appeared to be a fireball was seen streaking over wide areas of Japan. (NHK)
Jul 02
As Japan emerges from a state of emergency, the Yokohama City Seibu Hospital, once the site of one of the worst hit hospitals of the coronavirus outbreaks, is grappling to operate alongside a virus with no treatment or cure. (Reuters)